J Lustgarten,
AL Dominguez,
M Thoman.
(2004)
"Aged mice develop protective antitumor immune responses with appropriate costimulation."
J Immunol
173.
4510-5
PMID:
15383582
|
Abstract and Keywords
AB Pillai,
TI George,
S Dutt,
P Teo,
S Strober.
(2007)
"Host NKT cells can prevent graft-versus-host disease and permit graft antitumor activity after bone marrow transplantation."
J Immunol
178.
6242-51
PMID:
17475852
|
Abstract and Keywords
Y Chung,
H Qin,
CY Kang,
S Kim,
LW Kwak,
C Dong.
(2007)
"An NKT-mediated autologous vaccine generates CD4 T-cell dependent potent antilymphoma immunity."
Blood
110.
2013-9
PMID:
17581919
DOI:
10.1182/blood-2006-12-061309
|
Abstract and Keywords
GJ Renukaradhya,
MA Khan,
M Vieira,
W Du,
J Gervay-Hague,
RR Brutkiewicz.
(2008)
"Type I NKT cells protect (and type II NKT cells suppress) the host's innate antitumor immune response to a B-cell lymphoma."
Blood
111.
5637-45
PMID:
18417738
DOI:
10.1182/blood-2007-05-092866
|
Abstract and Keywords
D Assudani,
HI Cho,
N DeVito,
N Bradley,
E Celis.
(2008)
"In vivo expansion, persistence, and function of peptide vaccine-induced CD8 T cells occur independently of CD4 T cells."
Cancer Res
68.
9892-9
PMID:
19047170
DOI:
10.1158/0008-5472.CAN-08-3134
|
Abstract and Keywords
TI Saito,
HW Li,
M Sykes.
(2010)
"Invariant NKT Cells Are Required for Antitumor Responses Induced by Host-Versus-Graft Responses"
The Journal of Immunology
185.
2099-105
PMID:
20631307
DOI:
10.4049/jimmunol.0901985
|
Abstract and Keywords
TI Saito,
HW Li,
M Sykes.
(2010)
"Invariant NKT Cells Are Required for Antitumor Responses Induced by Host-Versus-Graft Responses."
J Immunol
185.
2099-105
PMID:
20631307
DOI:
10.4049/jimmunol.0901985
|
Abstract and Keywords